CTE — Cryosite Cashflow Statement
0.000.00%
Last trade - 00:00- AU$59.55m
- AU$65.02m
- AU$16.70m
Annual cashflow statement for Cryosite, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0 | — | — | — | 0.092 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2.52 | 1.41 | 2.74 | 2.06 | 2.82 |
| Capital Expenditures | -0.863 | -0.301 | -0.452 | -0.586 | -10.9 |
| Purchase of Fixed Assets | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | 0.003 | -0.922 | 1.18 | 0.166 | 0.119 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.86 | -1.22 | 0.727 | -0.42 | -10.7 |
| Financing Cash Flow Items | -0.005 | -0.028 | -2.47 | 0 | -0.211 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.181 | -0.796 | -3.5 | -1.29 | 5.12 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.46 | -0.61 | -0.028 | 0.357 | -2.82 |